213 related articles for article (PubMed ID: 19859740)
1. Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.
Levesque MC; Hobbs MR; O'Loughlin CW; Chancellor JA; Chen Y; Tkachuk AN; Booth J; Patch KB; Allgood S; Pole AR; Fernandez CA; Mwaikambo ED; Mutabingwa TK; Fried M; Sorensen B; Duffy PE; Granger DL; Anstey NM; Weinberg JB
Hum Genet; 2010 Feb; 127(2):163-82. PubMed ID: 19859740
[TBL] [Abstract][Full Text] [Related]
2. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.
Hobbs MR; Udhayakumar V; Levesque MC; Booth J; Roberts JM; Tkachuk AN; Pole A; Coon H; Kariuki S; Nahlen BL; Mwaikambo ED; Lal AL; Granger DL; Anstey NM; Weinberg JB
Lancet; 2002 Nov; 360(9344):1468-75. PubMed ID: 12433515
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria.
Levesque MC; Hobbs MR; Anstey NM; Vaughn TN; Chancellor JA; Pole A; Perkins DJ; Misukonis MA; Chanock SJ; Granger DL; Weinberg JB
J Infect Dis; 1999 Dec; 180(6):1994-2002. PubMed ID: 10558957
[TBL] [Abstract][Full Text] [Related]
4. Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.
Boutlis CS; Hobbs MR; Marsh RL; Misukonis MA; Tkachuk AN; Lagog M; Booth J; Granger DL; Bockarie MJ; Mgone CS; Levesque MC; Weinberg JB; Anstey NM
Am J Trop Med Hyg; 2003 Dec; 69(6):569-73. PubMed ID: 14740870
[TBL] [Abstract][Full Text] [Related]
5. Inducible nitric oxide synthase 2 promoter polymorphism and malaria disease severity in children in Southern Ghana.
Dzodzomenyo M; Ghansah A; Ensaw N; Dovie B; Bimi L; Quansah R; Gyan BA; Gyakobo M; Amoani B
PLoS One; 2018; 13(8):e0202218. PubMed ID: 30118498
[TBL] [Abstract][Full Text] [Related]
6. iNOS promoter variants and severe malaria in Ghanaian children.
Cramer JP; Mockenhaupt FP; Ehrhardt S; Burkhardt J; Otchwemah RN; Dietz E; Gellert S; Bienzle U
Trop Med Int Health; 2004 Oct; 9(10):1074-80. PubMed ID: 15482399
[TBL] [Abstract][Full Text] [Related]
7. NOS2 variants reveal a dual genetic control of nitric oxide levels, susceptibility to Plasmodium infection, and cerebral malaria.
Trovoada Mde J; Martins M; Ben Mansour R; Sambo Mdo R; Fernandes AB; Antunes Gonçalves L; Borja A; Moya R; Almeida P; Costa J; Marques I; Macedo MP; Coutinho A; Narum DL; Penha-Gonçalves C
Infect Immun; 2014 Mar; 82(3):1287-95. PubMed ID: 24379293
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide generation in children with malaria and the NOS2G-954C promoter polymorphism.
Planche T; Macallan DC; Sobande T; Borrmann S; Kun JF; Krishna S; Kremsner PG
Am J Physiol Regul Integr Comp Physiol; 2010 Nov; 299(5):R1248-53. PubMed ID: 20811009
[TBL] [Abstract][Full Text] [Related]
9. Inducible Nitric Oxide Synthase Promoter Haplotypes and Residential Traffic-Related Air Pollution Jointly Influence Exhaled Nitric Oxide Level in Children.
Salam MT; Lin PC; Eckel SP; Gauderman WJ; Gilliland FD
PLoS One; 2015; 10(12):e0145363. PubMed ID: 26714306
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic variations in inducible nitric oxide synthase promoter, particulate pollution, and exhaled nitric oxide levels in children.
Salam MT; Byun HM; Lurmann F; Breton CV; Wang X; Eckel SP; Gilliland FD
J Allergy Clin Immunol; 2012 Jan; 129(1):232-9.e1-7. PubMed ID: 22055874
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria.
Burgner D; Usen S; Rockett K; Jallow M; Ackerman H; Cervino A; Pinder M; Kwiatkowski DP
Hum Genet; 2003 Apr; 112(4):379-86. PubMed ID: 12552317
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria.
Kun JF; Mordmüller B; Perkins DJ; May J; Mercereau-Puijalon O; Alpers M; Weinberg JB; Kremsner PG
J Infect Dis; 2001 Aug; 184(3):330-6. PubMed ID: 11443559
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms in the NOS2 and NOS3 genes are associated with exhaled nitric oxide.
Dahgam S; Nyberg F; Modig L; Naluai AT; Olin AC
J Med Genet; 2012 Mar; 49(3):200-5. PubMed ID: 22368302
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans.
Oates JC; Levesque MC; Hobbs MR; Smith EG; Molano ID; Page GP; Hill BS; Weinberg JB; Cooper GS; Gilkeson GS
J Rheumatol; 2003 Jan; 30(1):60-7. PubMed ID: 12508391
[TBL] [Abstract][Full Text] [Related]
15. Association between recurrent aphthous stomatitis and inheritance of a single-nucleotide polymorphism of the NOS2 gene encoding inducible nitric oxide synthase.
Karasneh JA; Darwazeh AM; Hassan AF; Thornhill M
J Oral Pathol Med; 2011 Oct; 40(9):715-20. PubMed ID: 21481004
[TBL] [Abstract][Full Text] [Related]
16. Association of Nitric Oxide Synthase2 gene polymorphisms with leprosy reactions in northern Indian population.
Dubey A; Biswas SK; Sinha E; Chakma JK; Kamal R; Arora M; Sagar H; Natarajan M; Bhagyawant SS; Mohanty KK
Infect Genet Evol; 2017 Jul; 51():67-73. PubMed ID: 28315742
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the promoter region of iNOS predispose to rheumatoid arthritis in south Indian Tamils.
Negi VS; Mariaselvam CM; Misra DP; Muralidharan N; Fortier C; Charron D; Krishnamoorthy R; Tamouza R
Int J Immunogenet; 2017 Jun; 44(3):114-121. PubMed ID: 28374504
[TBL] [Abstract][Full Text] [Related]
18. Haplotypes of the inducible nitric oxide synthase gene are strongly associated with exhaled nitric oxide levels in adults: a population-based study.
Dahgam S; Modig L; Torinsson Naluai Å; Olin AC; Nyberg F
J Med Genet; 2014 Jul; 51(7):449-54. PubMed ID: 24729625
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region.
Anyona SB; Hengartner NW; Raballah E; Ong'echa JM; Lauve N; Cheng Q; Fenimore PW; Ouma C; Lambert CG; McMahon BH; Perkins DJ
J Hum Genet; 2020 Jan; 65(2):99-113. PubMed ID: 31664161
[TBL] [Abstract][Full Text] [Related]
20. No evidence for linkage in the promoter region of the inducible nitric oxide synthase gene (NOS2) in a Danish type 1 diabetes population.
Johannesen J; Pociot F; Kristiansen OP; Karlsen AE; Nerup J;
Genes Immun; 2000 Aug; 1(6):362-6. PubMed ID: 11196682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
